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Acute respiratory failure (ARF) is defined as hypoxemic or hypercarbic respiratory failure (PaO2<60 mmHg or SpO2 of ≤85%, with fraction of inspired oxygen [FiO2] ≥0.6 
and partial pressure of CO2 [PaCO2] >50 mmHg). Over the 
past two decades, non-invasive ventilation (NIV) has become 
the standard of care in treating ARF [1]. Several randomized 
controlled trials have shown that NIV improves dyspnea, gas 
exchange, and reduces the incidence of tracheal intubation [2]. 
Furthermore, compared to invasive mechanical ventilation, NIV 
reduces the length of intensive care unit (ICU) and hospital stay, 
morbidity, and mortality in patients with ARF [3].
NIV failure has been defined as the need for endotracheal 
intubation (ETI) or death. There has also been concern that NIV 
may delay intubation, leading to a worse outcome [4]. Several 
studies in adults have identified various factors which can predict 
NIV success [5-8]; however, studies in pediatric population are 
limited [1,9-11]. Thus, the objective of the study was to determine the 
predictors of NIV failure in pediatric acute respiratory distress/failure.
MATERIALS AND METHODS
This was a prospective observational study conducted in 
a multidisciplinary, 12-bedded, pediatric ICU (PICU) in a 
tertiary care hospital during October 2016–May 2018. The 
study was approved by the Institutional Ethical Committee 
and informed consent was taken from the parents. Children 
from 1 month to 16 years of age presenting with acute 
respiratory distress (according to PALS guidelines) or failure 
(defined as PaO2<60 mmHg or arterial oxygen saturation of 
≤85%, with FiO2≥0.6 and PaCO2>50 mmHg) were included 
in the study. Patients were selected regardless of underlying 
disease process contributing to respiratory distress including 
post-extubation.
Children requiring immediate intubation (<1 h), 
low level of consciousness (Glasgow coma scale <10), 
absent cough/gag reflex, polytrauma, hemoptysis/copious 
respiratory secretions, facial injuries/burns, nasopharyngeal 
obstruction, hemodynamic instability, recent facial, upper 
airway or upper gastrointestinal tract surgery (<7 days), 
undrained pneumothorax, or basilar skull fracture/craniofacial 
malformations were excluded from the study. The reported 
success rate of NIV in a study by Bernet et al. [1] was 57%. 
Hence, to estimate the success rate of NIV with 9.5% absolute 
precision and 95% confidence interval (CI), the required 
minimum sample size was 104 children.
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Protocol for NIV Use in the PICU
NIV was provided using either conventional ventilator with NIV 
pressure support/pressure control mode (Maquet servo-i ventilator 
with NIV-PS/PC mode) or a bilevel positive airway pressure 
(Weinmann ME17 0011). NIV-PS/PC mode on ventilator was 
used when precise titration of FiO2 was mandatory as in hypoxic 
respiratory failure. Initial settings and titration of PS were 
done as shown in Fig. 1 and FiO2 was adjusted to maintain the 
SpO2>94%. A backup ventilator frequency (“backup rate”) was 
set at two breaths below the patient’s spontaneous rate in case 
the patient becomes apneic. Patients were propped up at an angle 
of 30–45° to prevent reflux, aspiration, and ventilator-associated 
pneumonia. Nasogastric tube was inserted and decompression 
was done. Application of skin protectant barrier was considered to 
prevent skin breakdown. For NIV interface, a nasal mask/oronasal 
mask was used and adjusted for acceptable air leakage (20%). 
A baseline arterial blood gas (ABG) analysis was performed after 
patient’s stabilization on NIV.
Demographic details such as age, gender, pediatric risk 
of mortality score (PRISM) III scores, primary diagnosis, 
and associated comorbid illness were tabulated. PRISM III 
was calculated using online-based PRISM III calculator. The 
following data were collected prospectively before initiating 
NIV and post-NIV at period intervals at 1 and 6 h: Respiratory 
rate (RR), heart rate (HR), transcutaneous oxygen saturation 
(SpO2), FiO2, and ABG (pH, PaO2, PCO2, and HCO3). Each 
patient was evaluated periodically according to the institutional 
protocol by the attending physician to access the possibility to 
decrease or increase expiratory positive airway pressure or NIV 
discontinuation/continuation.
Identification of NIV failure and indications for ETI was 
on the basis of the judgment of the attending physician which 
included inability to protect the airways or to manage copious 
tracheal secretions, hemodynamic or electrocardiographic 
instability, inability to tolerate the face mask, inability to correct 
dyspnea, and progression of respiratory failure (Fig. 1).
The outcome was to determine the predictors of NIV failure in 
pediatric acute respiratory distress/failure. Patients were divided 
into NIV failure and success groups, depending on whether they 
failed NIV and had to be intubated. NIV was ceased every 4 h 
to look for any complications attributable to NIV. We followed 
standardized protocol for weaning patients from NIV. Once 
improved, child was put on oxygen by face mask, nasal prongs, or 
onto room air. The outcome variables were analyzed and patients 
were followed up till day 28.
For comparisons between responders and non-responders, 
categorical variables were analyzed using Chi-square test. 
Approximately, normally distributed variables were compared 
with two-sample t-tests and skewed variables with Wilcoxon 
rank sums tests. The courses of vital and blood gas variables of 
responders and non-responders were compared by analysis of 
variance with repeated measures. Variables that were significantly 
different between responders and non-responders were entered 
a multiple logistic regression model to determine adjusted odds 
ratios (AORs) and 95% CIs and define which variables were 
independently associated with NIV failure. All continuous 
variables are presented as the mean (standard deviation) or 
median (interquartile range [IQR]). 28 days survival curves 
between responders and non-responders were compared using 
log-rank test. The median survival time was calculated using 
Kaplan–Meier method. For all analyses, p<0.05 was considered 
statistically significant. All data analyses were performed using 
R-3.5.0 software.
RESULTS
During the study period, 264 children presented with acute 
respiratory distress/failure; out of which, 156 were excluded either 
for requirement of immediate intubation or due to the presence 
of other exclusion criteria and 108 patients (40%) received NIV. 
The overall success rate of NIV was 81.48%, failure occurred in 
18.51% of cases.
The baseline characteristics of studied patients are presented in 
Table 1. Median age was 7.5 years (IQR 4, 10.5) and male:female 
ratio was 1.29:1. The main etiologies of acute respiratory distress/
failure did not differ between the two groups, but the majority of 
patients received NIV for bronchopneumonia. No relationship was 
found between the outcome (success/failure) and age, sex, and 
underlying disease. Comorbid illnesses were present in 27 patients 
(25%). The median PRISM III score for the NIV failure group 
was significantly higher compared to success group (p =.025) and 
more patients in failure group had comorbid illness (p=0.001), 
suggesting these variables as predictive factors for NIV failure.
Eight patients (7.4%) developed minor complications such 
as skin erosions. NIV failure was observed between 1 and 50 h. 
Table 1: Baseline characteristics and outcome of study population
Variable Study population (n=108) NIV responders (n=88) Non-responders (n=20) p value
Age (years) median (IQR) 7.5 (4,10.5) 7.5 (4,11) 7.5 (5,10) 0.762
Male: female 1.29:1 1.3:1 1.2:1 0.882
Comorbid illness 27 16 (18.18%) 11 (55%) 0.001*
PRISM III score (median) IQR 7 (5,8) 7 (4.5,8) 8 (6.5,13.5) 0.025*
Duration of NIV (h) median (IQR) 36 (24,48) 40 (29,50) 11 (6.5,15) <0.001*
Duration of ICU stay (h) median (IQR) 4 (3,6) 4 (3,5) 8 (5,11.5) 0.001*
Duration of hospital stay (h) median (IQR) 10 (7.5,15) 9 (7,12) 15.5 (12,24.5) 0.001*
In hospital mortality 15 4 (4.5%) 11 (55%) <0.001*
*p<0.05 - significant. IQR: Interquartile range, ICU: Intensive care unit, NIV: Non-invasive ventilation, PRISM: Pediatric risk of mortality
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Total 9 of 20 patients got intubated within 8 h, nine in the next 
16 h, and only two failures were noted past the first 24 h. It 
was observed that the median duration of NIV (40 [29, 50] vs. 
11 [6.5, 15]), PICU stay (4 [3, 5] vs. 8 [5, 11.5]), and hospital 
stay (9 [7, 12] vs. 15.5 [12, 24, 5] was significantly longer 
among the NIV failure compared with the NIV success group 
Figure 1: Protocol for initiation and monitoring of non-invasive ventilation
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[Fig. 2]. Fig. 3 shows the Trends of heart rate, respiratory rate, 
SpO2, and pH among responders and non-responders at 0, 1, 
and 6 h.
Baseline values of the variables did not differ between groups 
except pH at admission which was significantly lower amongst 
failure group as compared to success group (p=0.021). Analysis 
of clinical and blood gas variables data showed an overall 
significant decrease in RR, HR, SpO2, and improvement in blood 
gases (pH, PO2, PCO2, and HCO3) from admission to 1 h and 
maintained through 6 h NIV (p<0.001) (Table 2). Although these 
variables decreased more in the success group, the difference was 
not statistically significant between the two groups.
Logistic regression analysis containing three independent 
variables (PRISM III score, presence of comorbid illness, and pH 
at admission) to predict NIV failure was also done. The presence of 
comorbid illness remains the statistically significant independent 
predictor of NIV failure, with OR of 4.24 (95% CI 1.322–13.576) 
p=0.015, whereby patients with the presence of comorbid illness 
were much more likely to fail NIV and require intubation (Table 3).
DISCUSSION
This study showed a success rate of NIV in children with 
respiratory distress/failure to be 81.5% which was similar to 





OR 95% CI p value
Comorbid illness 4.24 1.322–13.576 0.015*
PRISM III score 1.074627 0.9332397–1.237435 0.317
Admission pH 0.0015 4.53–5.36 0.12
OR: Odds ratio, CI: Confidence interval, *p value - significant. NIV: Non-invasive 
ventilation, PRISM: Pediatric risk of mortality
Comorbid illness 27 16 (18.18%) 11 (55%) 0.001
Kidney disease 17 11 (%) 6
Chronic liver disease 1 0 1
Congenital heart disease 3 2 1
Hematoncologic diseases 6 3 3
Figure 2: Kaplan–Meier curve for 28-day survival
Table 2: Clinical and blood gas variables pre-NIV and post-NIV (1, 6 h)
Variable Before NIV After 1 h p value (0,1) After 6 h p value (0,6)
HR 127.29±23.38 116.88±23 <0.001* 110.68±21.46 <0.001*
RR 44.58±12.26 41.04±10.93 <0.001* 36.51±8.79 <0.001*
SpO2 96.68±3.36 98.74±1.59 <0.001* 99.06±1.45 <0.001*
pH 7.08±0.07 7.37±0.07 0.24 7.40±0.07 0.89
PCO2 32.18±6.79 31.97±5.83 0.721 33.97±7.71 0.056
PO2 90.65±36 124.47±45 <0.001* 127.99±40.09 <0.001*
NIV: Non-invasive ventilation, Pre-NIV: Prospectively before initiating NIV, HR: Heart rate, RR: Respiratory rate
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other studies [12,13]. Therefore, we suggest that NIV can be 
successfully used in children with acute respiratory distress/
failure of varied etiology in the PICU.
Our study population was a heterogeneous group with 
bronchopneumonia being the most common cause for the need of 
NIV support, comprising 44% and was similar to other pediatric 
ARF studies [1,14-16]. Further, analysis of our study for predictors 
of NIV failure showed results similar to Bonet et al. [13] where no 
relationship was found between the outcome (success/failure) and 
sex, underlying disease, and type of respiratory failure. However, 
PRISM III score at admission was higher in NIV failure group 
and was statistically significant. This observation is similar to 
Caples et al. and other studies [10,18-21] where success in the 
use of NIV in their population of patients was largely dependent 
on the illness severity. Another interesting finding of our study 
was the result of multivariable analysis which showed that the 
presence of comorbid illness was independently associated with 
increased risk of NIV failure, and therefore, we suggest careful 
selection of these patients at admission for NIV use.
In relation to the outcome of NIV, our results were similar to 
a study by Correa et al. [22] where NIV failure was associated 
with increased mortality rates and longer length of PICU and 
hospital stay. Furthermore, NIV application only caused minor 
complications which were interface related.
Clinical and blood gas variables showed improvement at 1 
h and maintained at 6 h of post-NIV. Although these variables 
decreased more in the success group, the difference was not 
statistically significant. These results are comparable to a study by 
Bernet et al. [1] emphasizing the requirement of close monitoring 
in these patients.
Large sample size and application of NIV over varied etiology 
add to the strength of the study. However, there were certain 
limitations. This was a single-centric observational study; further, 
multicenter randomized controlled trials are required to comment 
on the efficacy of NIV therapy. Also, identification of NIV failure 
and indications for ETI was on basis of the judgment of the 
attending physician, which counted as another limitation.
CONCLUSION
NIV can be successfully used in children with acute respiratory 
distress/failure of varied etiology in the PICU. Patients with 
higher PRISM III score, presence of comorbid illness, and lower 
pH at admission had higher failure rates, suggesting the need for 
a careful monitoring of these patients. Further studies are needed 
to select the right treatment at the initial point of contact in the 
patient with acute respiratory distress/failure.
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